Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

Does Private Insurance Cover Cannabis for Mood Disorders Like Depression? 

Posted
Updated
ByMy Patient Advice
Author: Dr. Clarissa Morton, PharmD

The question of UK private insurance and cannabis for depression  is becoming more relevant as patients turn to private clinics for access. While medical cannabis has been legal since 2018, most prescriptions for depression are only available privately, making affordability a concern. Unfortunately, the majority of private insurers do not include cannabis in their coverage policies, viewing it as an unapproved or experimental treatment. 

This means patients are often responsible for the full treatment cost, which can include initial consultations, prescriptions, and ongoing follow-up appointments. Some insurers may offer partial support if cannabis is prescribed for another recognised condition, but depression rarely qualifies. 

Is Medical Cannabis Legal in UK?

Insurance And Access to Care 

Understanding the position of UK private insurance on cannabis for depression requires looking at how insurers handle reimbursement and eligibility. 

Treatment Cost 

Patients face significant treatment costs, with monthly prescriptions adding up quickly. Without insurance, this remains one of the biggest barriers to access. 

Reimbursement 

In most cases, insurers do not offer reimbursement for cannabis prescribed for depression. Exceptions are rare and usually linked to other approved medical conditions. 

Coverage Policies 

Strict coverage policies mean cannabis remains outside mainstream health insurance plans. Until more clinical evidence is accepted, insurers are unlikely to expand support for depression-related use. 

In summary, while UK private insurance and cannabis for depression would make treatment more accessible, current coverage is very limited. Patients considering this route should be prepared for out-of-pocket expenses. 

For those exploring private access and affordability, providers like LeafEase can offer consultations to help clarify treatment options and potential costs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Depression.  

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories